Prognostic significance of histological grade in low-risk endometrial cancer

Objective: Investigate the risk factors for recurrence in patients with low-risk endometrial cancer. Method: A retrospective review was performed to identify patients who underwent primary surgical treatment for endometrial cancer from December 2009 to December 2020. Patients who met the following c...

Full description

Saved in:
Bibliographic Details
Published in:International journal of medical sciences 2022-01, Vol.19 (13), p.1875-1878
Main Authors: Bak, Seong Eun, Yoo, Ji Geun, Lee, Sung Jong, Yoon, Joo Hee, Park, Dong Choon, Kim, Sang Il
Format: Article
Language:English
Subjects:
Body mass index
Cancer therapies
Endometrial cancer
Lymphatic system
Medical prognosis
Menopause
Multivariate analysis
Radiation therapy
Risk factors
Surgery
Uterine cancer
Vagina
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c394t-2d4e71ec48fbb4f3c8fe64f65d76072119d749c0656000cffee2ed418ec605b23
cites
container_end_page 1878
container_issue 13
container_start_page 1875
container_title International journal of medical sciences
container_volume 19
creator Bak, Seong Eun
Yoo, Ji Geun
Lee, Sung Jong
Yoon, Joo Hee
Park, Dong Choon
Kim, Sang Il
description Objective: Investigate the risk factors for recurrence in patients with low-risk endometrial cancer. Method: A retrospective review was performed to identify patients who underwent primary surgical treatment for endometrial cancer from December 2009 to December 2020. Patients who met the following criteria were included in the study: (a) International Federation of Gynecology and Obstetrics stage IA, (b) endometrioid-type histology, (c) histological grade 1 or 2. Univariate and multivariate analyses using Cox proportional hazards model to evaluate effects of prognostic factors. Disease-free survival and overall survival were calculated using the Kaplan-Meier method. Results: A total of 171 patients with low-risk endometrial cancer were included in the study. Recurrence was detected in 9 patients. Histological grade was found to be independent risk factors for recurrence in women with low-risk endometrial cancer (OR 8.255, 95% confidence interval (CI) 1.585 - 42.981; p = 0.012). Conclusion: The results of this study suggest that grade 2 disease should be considered a significant prognostic factor for the recurrence of low-risk endometrial cancer.
doi_str_mv 10.7150/ijms.77152
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2740906077</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2737141857</sourcerecordid><originalsourceid>FETCH-LOGICAL-c394t-2d4e71ec48fbb4f3c8fe64f65d76072119d749c0656000cffee2ed418ec605b23</originalsourceid><addsrcrecordid>eNpdkMFKAzEQhoMoWKsXnyDgRYStk2x20z1KsSoU9KDnsM1O1tTdpCZbxLc323oQTzPMfPMzfIRcMphJVsCt3fRxJlPLj8iECVFlrAJ5_Kc_JWcxbgBynks2IauX4Fvn42A1jbZ11lhdO43UG_pu4-A736ZJR9tQN0ito53_yoKNHxRd43scgk3b_U04Jyem7iJe_NYpeVvevy4es9Xzw9PibpXpvBJDxhuBkqEWc7NeC5PrucFSmLJoZAmSM1Y1UlQayqIEAG0MIsdGsDnqEoo1z6fk-pC7Df5zh3FQvY0au6526HdRcSmggpQlE3r1D934XXDpu0QlAym1GKmbA6WDjzGgUdtg-zp8KwZqFKtGsWovNv8BkxJrzw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2737141857</pqid></control><display><type>article</type><title>Prognostic significance of histological grade in low-risk endometrial cancer</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Bak, Seong Eun ; Yoo, Ji Geun ; Lee, Sung Jong ; Yoon, Joo Hee ; Park, Dong Choon ; Kim, Sang Il</creator><creatorcontrib>Bak, Seong Eun ; Yoo, Ji Geun ; Lee, Sung Jong ; Yoon, Joo Hee ; Park, Dong Choon ; Kim, Sang Il</creatorcontrib><description>Objective: Investigate the risk factors for recurrence in patients with low-risk endometrial cancer. Method: A retrospective review was performed to identify patients who underwent primary surgical treatment for endometrial cancer from December 2009 to December 2020. Patients who met the following criteria were included in the study: (a) International Federation of Gynecology and Obstetrics stage IA, (b) endometrioid-type histology, (c) histological grade 1 or 2. Univariate and multivariate analyses using Cox proportional hazards model to evaluate effects of prognostic factors. Disease-free survival and overall survival were calculated using the Kaplan-Meier method. Results: A total of 171 patients with low-risk endometrial cancer were included in the study. Recurrence was detected in 9 patients. Histological grade was found to be independent risk factors for recurrence in women with low-risk endometrial cancer (OR 8.255, 95% confidence interval (CI) 1.585 - 42.981; p = 0.012). Conclusion: The results of this study suggest that grade 2 disease should be considered a significant prognostic factor for the recurrence of low-risk endometrial cancer.</description><identifier>ISSN: 1449-1907</identifier><identifier>EISSN: 1449-1907</identifier><identifier>DOI: 10.7150/ijms.77152</identifier><language>eng</language><publisher>Wyoming: Ivyspring International Publisher Pty Ltd</publisher><subject>Body mass index ; Cancer therapies ; Endometrial cancer ; Lymphatic system ; Medical prognosis ; Menopause ; Multivariate analysis ; Radiation therapy ; Risk factors ; Surgery ; Uterine cancer ; Vagina</subject><ispartof>International journal of medical sciences, 2022-01, Vol.19 (13), p.1875-1878</ispartof><rights>2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c394t-2d4e71ec48fbb4f3c8fe64f65d76072119d749c0656000cffee2ed418ec605b23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2737141857/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2737141857?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,4010,25733,27902,27903,27904,36991,36992,44569,74872</link.rule.ids></links><search><creatorcontrib>Bak, Seong Eun</creatorcontrib><creatorcontrib>Yoo, Ji Geun</creatorcontrib><creatorcontrib>Lee, Sung Jong</creatorcontrib><creatorcontrib>Yoon, Joo Hee</creatorcontrib><creatorcontrib>Park, Dong Choon</creatorcontrib><creatorcontrib>Kim, Sang Il</creatorcontrib><title>Prognostic significance of histological grade in low-risk endometrial cancer</title><title>International journal of medical sciences</title><description>Objective: Investigate the risk factors for recurrence in patients with low-risk endometrial cancer. Method: A retrospective review was performed to identify patients who underwent primary surgical treatment for endometrial cancer from December 2009 to December 2020. Patients who met the following criteria were included in the study: (a) International Federation of Gynecology and Obstetrics stage IA, (b) endometrioid-type histology, (c) histological grade 1 or 2. Univariate and multivariate analyses using Cox proportional hazards model to evaluate effects of prognostic factors. Disease-free survival and overall survival were calculated using the Kaplan-Meier method. Results: A total of 171 patients with low-risk endometrial cancer were included in the study. Recurrence was detected in 9 patients. Histological grade was found to be independent risk factors for recurrence in women with low-risk endometrial cancer (OR 8.255, 95% confidence interval (CI) 1.585 - 42.981; p = 0.012). Conclusion: The results of this study suggest that grade 2 disease should be considered a significant prognostic factor for the recurrence of low-risk endometrial cancer.</description><subject>Body mass index</subject><subject>Cancer therapies</subject><subject>Endometrial cancer</subject><subject>Lymphatic system</subject><subject>Medical prognosis</subject><subject>Menopause</subject><subject>Multivariate analysis</subject><subject>Radiation therapy</subject><subject>Risk factors</subject><subject>Surgery</subject><subject>Uterine cancer</subject><subject>Vagina</subject><issn>1449-1907</issn><issn>1449-1907</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkMFKAzEQhoMoWKsXnyDgRYStk2x20z1KsSoU9KDnsM1O1tTdpCZbxLc323oQTzPMfPMzfIRcMphJVsCt3fRxJlPLj8iECVFlrAJ5_Kc_JWcxbgBynks2IauX4Fvn42A1jbZ11lhdO43UG_pu4-A736ZJR9tQN0ito53_yoKNHxRd43scgk3b_U04Jyem7iJe_NYpeVvevy4es9Xzw9PibpXpvBJDxhuBkqEWc7NeC5PrucFSmLJoZAmSM1Y1UlQayqIEAG0MIsdGsDnqEoo1z6fk-pC7Df5zh3FQvY0au6526HdRcSmggpQlE3r1D934XXDpu0QlAym1GKmbA6WDjzGgUdtg-zp8KwZqFKtGsWovNv8BkxJrzw</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Bak, Seong Eun</creator><creator>Yoo, Ji Geun</creator><creator>Lee, Sung Jong</creator><creator>Yoon, Joo Hee</creator><creator>Park, Dong Choon</creator><creator>Kim, Sang Il</creator><general>Ivyspring International Publisher Pty Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20220101</creationdate><title>Prognostic significance of histological grade in low-risk endometrial cancer</title><author>Bak, Seong Eun ; Yoo, Ji Geun ; Lee, Sung Jong ; Yoon, Joo Hee ; Park, Dong Choon ; Kim, Sang Il</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c394t-2d4e71ec48fbb4f3c8fe64f65d76072119d749c0656000cffee2ed418ec605b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Body mass index</topic><topic>Cancer therapies</topic><topic>Endometrial cancer</topic><topic>Lymphatic system</topic><topic>Medical prognosis</topic><topic>Menopause</topic><topic>Multivariate analysis</topic><topic>Radiation therapy</topic><topic>Risk factors</topic><topic>Surgery</topic><topic>Uterine cancer</topic><topic>Vagina</topic><toplevel>online_resources</toplevel><creatorcontrib>Bak, Seong Eun</creatorcontrib><creatorcontrib>Yoo, Ji Geun</creatorcontrib><creatorcontrib>Lee, Sung Jong</creatorcontrib><creatorcontrib>Yoon, Joo Hee</creatorcontrib><creatorcontrib>Park, Dong Choon</creatorcontrib><creatorcontrib>Kim, Sang Il</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bak, Seong Eun</au><au>Yoo, Ji Geun</au><au>Lee, Sung Jong</au><au>Yoon, Joo Hee</au><au>Park, Dong Choon</au><au>Kim, Sang Il</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic significance of histological grade in low-risk endometrial cancer</atitle><jtitle>International journal of medical sciences</jtitle><date>2022-01-01</date><risdate>2022</risdate><volume>19</volume><issue>13</issue><spage>1875</spage><epage>1878</epage><pages>1875-1878</pages><issn>1449-1907</issn><eissn>1449-1907</eissn><abstract>Objective: Investigate the risk factors for recurrence in patients with low-risk endometrial cancer. Method: A retrospective review was performed to identify patients who underwent primary surgical treatment for endometrial cancer from December 2009 to December 2020. Patients who met the following criteria were included in the study: (a) International Federation of Gynecology and Obstetrics stage IA, (b) endometrioid-type histology, (c) histological grade 1 or 2. Univariate and multivariate analyses using Cox proportional hazards model to evaluate effects of prognostic factors. Disease-free survival and overall survival were calculated using the Kaplan-Meier method. Results: A total of 171 patients with low-risk endometrial cancer were included in the study. Recurrence was detected in 9 patients. Histological grade was found to be independent risk factors for recurrence in women with low-risk endometrial cancer (OR 8.255, 95% confidence interval (CI) 1.585 - 42.981; p = 0.012). Conclusion: The results of this study suggest that grade 2 disease should be considered a significant prognostic factor for the recurrence of low-risk endometrial cancer.</abstract><cop>Wyoming</cop><pub>Ivyspring International Publisher Pty Ltd</pub><doi>10.7150/ijms.77152</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1449-1907
ispartof International journal of medical sciences, 2022-01, Vol.19 (13), p.1875-1878
issn 1449-1907
1449-1907
language eng
recordid cdi_proquest_miscellaneous_2740906077
source Publicly Available Content Database; PubMed Central
subjects Body mass index
Cancer therapies
Endometrial cancer
Lymphatic system
Medical prognosis
Menopause
Multivariate analysis
Radiation therapy
Risk factors
Surgery
Uterine cancer
Vagina
title Prognostic significance of histological grade in low-risk endometrial cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T17%3A32%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20significance%20of%20histological%20grade%20in%20low-risk%20endometrial%20cancer&rft.jtitle=International%20journal%20of%20medical%20sciences&rft.au=Bak,%20Seong%20Eun&rft.date=2022-01-01&rft.volume=19&rft.issue=13&rft.spage=1875&rft.epage=1878&rft.pages=1875-1878&rft.issn=1449-1907&rft.eissn=1449-1907&rft_id=info:doi/10.7150/ijms.77152&rft_dat=%3Cproquest_cross%3E2737141857%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c394t-2d4e71ec48fbb4f3c8fe64f65d76072119d749c0656000cffee2ed418ec605b23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2737141857&rft_id=info:pmid/&rfr_iscdi=true